The single most important aspect of pharmacotherapy for Schizophrenia is drug compliance. Nonadherence to medication is a recognized problem and may be the most challenging aspect of treatment. High rates of poor compliance with its potentially severe consequences and associated costs make the phenomenon a priority issue. This books analyses and dissects the modifiable and non modifiable factors which are likely to influence this basic tenet of therapy for Schizophrenia.